摘要 |
The present invention relates to compounds of the formula (I), wherein R<SUP>1</SUP> and R<SUP>2</SUP> are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/ or prophylaxis of diseases which are associated with DPP-IV, such as diabetes, non-insulin dependent diabetes mellitus and/or impaired glucose tolerance, obesity, and/or metabolic syndrome or ß-cell protection.
|
申请人 |
F. HOFFMANN-LA ROCHE AG;BOEHRINGER, MARKUS;HUNZIKER, DANIEL;KUHN, BERND;LOEFFLER, BERND, MICHAEL;LUEBBERS, THOMAS;RICKLIN, FABIENNE |
发明人 |
BOEHRINGER, MARKUS;HUNZIKER, DANIEL;KUHN, BERND;LOEFFLER, BERND, MICHAEL;LUEBBERS, THOMAS;RICKLIN, FABIENNE |